This inventor holds 2 USPTO granted patents. Top assignees: Nektar Therapeutics, Novartis Ag. Active years: 2008-2013.
Company Filing History:
Years Active: 2008-2013
Title: Richard Malcolmson: Innovator in Amphotericin B Compositions
Introduction
Richard Malcolmson is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of pharmaceutical compositions, particularly focusing on amphotericin B. With a total of 2 patents, his work has implications for the treatment of various medical conditions.
Latest Patents
Malcolmson's latest patents include innovative compositions and formulations comprising amphotericin B. One patent details methods and systems for creating these compositions, which include formulations with one or more excipients. Additionally, he has developed pharmaceutical compositions that involve methods of administering these formulations and treating patients effectively. Another patent focuses on compositions that include particles with a high concentration of amphotericin B, specifically targeting the mass median diameter of these particles to enhance their efficacy.
Career Highlights
Throughout his career, Richard Malcolmson has worked with prominent companies in the pharmaceutical industry, including Nektar Therapeutics and Novartis AG. His experience in these organizations has allowed him to refine his expertise in drug formulation and delivery systems.
Collaborations
Malcolmson has collaborated with notable colleagues such as Theresa D. Sweeney and Danforth Miller. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Richard Malcolmson's innovative work in amphotericin B compositions showcases his dedication to improving pharmaceutical formulations. His contributions are vital for advancing treatment options in the medical field.